Cover Image
Market Research Report
Product code 
1084385

Disease Control and Prevention Vaccine Market - Global Forecast, 2022 - 2028

Published: | Coherent Market Insights | 210 Pages | Delivery time: 2-3 business days

Price

Back to Top
Disease Control and Prevention Vaccine Market - Global Forecast, 2022 - 2028
Published: May 27, 2022
Coherent Market Insights
Content info: 210 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

Vaccines are the biological preparation used for stimulating antibody production to activate immune system against diseases such as influenza, Hepatitis A, Hepatitis B, Human Papillomavirus, Polio, and Rabies. High prevalence of infectious disease and increasing governmental initiative for implementing nationalized vaccination programme are expected to drive growth of the vaccine market, whereas high developmental cost of vaccine is expected to hamper growth of the vaccine market. For instance, according to the Centers for Disease Control and Prevention (CDC), 2015, flu vaccinations prevented an around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

Market Dynamics

The global disease control and prevention vaccine market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel vaccines such as recombinant and cell-based technologies, resulting in increasing production of the vaccines. For instance, in 2018, collaboration between Austrian biotech Themis Bioscience and Oslo-based Coalition for Epidemic Preparedness Innovations (CEIP). CEIP will fund US$ 37.5 million for vaccine development for five years. Moreover, governmental bodied supports the research and development program leading to the development of improved form of presently available vaccines. For instance, in 2015, a National Institute of Allergy and Infectious Disease scientists engineered a protein to maintain the specific shape of the viral spike, stimulating the immune system to produce powerful anti-HIV antibodies. However, manufacturing cost as well as large gap between demand and supply leading to hike in pricing is expected to hinder the growth of disease control and prevention vaccination market.

Key features of the study:

This report provides in-depth analysis of the disease control and prevention vaccine  market and its Type, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global disease control and prevention vaccine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies

Key companies covered as a part of this study include GlaxoSmithKline plc (GSK), Merck & Co. Inc., Sanofi, AstraZeneca PLC, Pfizer, Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Astellas Pharma Inc., and Daiichi Sankyo

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.

The global disease control and prevention vaccine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for disease control and prevention vaccine market, research and consulting firms, new entrants and financial analysts.

Detailed Segmentation:

Global Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Global Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Global Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Global Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Global Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Global Disease Control and Prevention Vaccine Market, By Region:

North America

U.S.

U.S. Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

U.S. Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

U.S. Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

U.S. Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

U.S. Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Canada

Canada Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Canada Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Canada Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Canada Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Canada Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Europe

U.K.

U.K. Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

U.K. Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

U.K. Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

U.K. Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

U.K. Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Germany

Germany Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Germany Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Germany Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Germany Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Germany Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Italy

Italy Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Italy Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Italy Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Italy Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Italy Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

France

France Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

France Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

France Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

France Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

France Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Spain

Spain Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Spain Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Spain Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Spain Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Spain Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Russia

Russia Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Russia Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Russia Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Russia Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Russia Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Rest of Europe

Rest of Europe Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Rest of Europe Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Rest of Europe Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Rest of Europe Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Rest of Europe Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Asia-Pacific

China

China Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

China Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

China Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

China Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

China Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

India

India Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

India Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

India Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

India Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

India Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Japan

Japan Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Japan Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Japan Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Japan Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Japan Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

ASEAN

ASEAN Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

ASEAN Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

ASEAN Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

ASEAN Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

ASEAN Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Australia

Australia Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Australia Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Australia Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Australia Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Australia Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

South Korea

South Korea Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

South Korea Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

South Korea Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

South Korea Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

South Korea Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Rest of Asia Pacific

Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Latin America

Brazil

Brazil Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Brazil Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Brazil Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Brazil Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Brazil Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Mexico

Mexico Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Mexico Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Mexico Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Mexico Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Mexico Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Rest of Latin America

Rest of Latin America Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Rest of Latin America Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Rest of Latin America Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Rest of Latin America Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Rest of Latin America Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Middle East

GCC

GCC Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

GCC Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

GCC Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

GCC Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

GCC Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Israel

Israel Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Israel Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Israel Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Israel Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Israel Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Rest of Middle East

Rest of Middle East Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Rest of Middle East Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Rest of Middle East Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Rest of Middle East Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Rest of Middle East Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Africa

North Africa

North Africa Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

North Africa Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

North Africa Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

North Africa Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

North Africa Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Central Africa

Central Africa Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

Central Africa Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

Central Africa Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

Central Africa Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

Central Africa Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

South Africa

South Africa Disease Control and Prevention Vaccine Market, By Product Type:

Live-attenuated Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid Vaccines

South Africa Disease Control and Prevention Vaccine Market, By Type:

Monovalent Vaccine

Multivalent Vaccine

South Africa Disease Control and Prevention Vaccine Market, By Route of Administration:

Oral

Injectable

South Africa Disease Control and Prevention Vaccine Market, By Age Group:

Pediatric

Adults

South Africa Disease Control and Prevention Vaccine Market, By Indication:

Infectious Disease

Cancer

Other Indication

Company Profiles

GlaxoSmithKline plc (GSK) *

Company Overview

Product Portfolio

Financial Performance

Recent Highlights

Strategies

Merck & Co. Inc.

Sanofi

AstraZeneca PLC

Pfizer, Inc.

Serum Institute of India Pvt. Ltd.

Sinovac Biotech Ltd.

Astellas Pharma Inc.

Daiichi Sankyo

“*” marked represents similar segmentation in other categories in the respective section.

Product Code: CMI1500

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Age Group
    • Market Snippet, By Indication
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Governmental Initiative
  • Product Pipeline
  • Regulatory Landscape
  • PEST Analysis
  • PORTER'S Five Forces

4. Global Disease Control and Prevention Vaccines Market, By Product Type, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Live-attenuated Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Inactivated Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Recombinant Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Toxoid Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Disease Control and Prevention Vaccines Market, By Type, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Monovalent Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Multivalent Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Disease Control and Prevention Vaccines Market, By Route of Administration, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Disease Control and Prevention Vaccines Market, By Age Group, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Pediatric Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Adult Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Disease Control and Prevention Vaccines Market, By Indication, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Other Indications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

9. Global Disease Control and Prevention Vaccines Market, By Regions, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2028
    • Regional Trends
  • North America
    • U.S.
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Canada
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
  • Europe
    • U.K.
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Germany
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Italy
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • France
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Spain
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Russia
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Rest of Europe
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
  • Asia Pacific
    • China
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Japan
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • India
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • ASEAN
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Australia
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • South Korea
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Rest of Asia Pacific
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
  • Latin America
    • Brazil
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Mexico
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Rest of Latin America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
  • Africa
    • Northern Africa
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Central Africa
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • South Africa
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
  • Middle East
    • GCC Countries
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Israel
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Rest of Middle East
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Age Group, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)

10. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • GlaxoSmithKline plc (GSK)
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Merck & Co. Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Sanofi
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • AstraZeneca PLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Serum Institute of India Pvt. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Sinovac Biotech Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Astellas Pharma Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Daiichi Sankyo
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact